Outcome analysis of HER2-zero or HER2-low hormone receptor-positive (HR plus ) breast cancer patients - characterization of the molecular phenotype in combination with molecular subtyping

CANCER RESEARCH(2023)

Cited 0|Views27
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined